Sovateltide |
IRL-1620; PMZ-1620; SPI-1620 |
Approved |
University Of Illinois At Chicago |
Tyvalzi |
India |
Stroke |
Pharmazz Inc |
2023-05-31 |
Biliary Tract Neoplasms; Brain Ischemia; Carcinoma; Spinal Cord Injuries; Asphyxia Neonatorum; Brain Diseases; Stroke; Ischemic Stroke; Dementia; Alzheimer Disease; Hypoxia-Ischemia, Brain; Cerebral Infarction; Carcinoma, Non-Small-Cell Lung |
Details
|
Macitentan/Tadalafil |
|
Approved |
Actelion Pharmaceuticals Ltd |
OPSYNVI, Yuvanci |
United States |
Pulmonary Arterial Hypertension |
Actelion Pharmaceuticals Us Inc |
2024-03-22 |
Phenylketonurias; Pulmonary Arterial Hypertension |
Details
|
Bosentan Hydrate |
ACT-050088; HGP-1206; Ro-47-0203; Ro-47-0203/029; Ro-47-0203/039 |
Approved |
F. Hoffmann-La Roche Ltd |
Stayveer, 全可利, Tracleer |
United States |
Pulmonary Arterial Hypertension |
Actelion Pharmaceuticals Ltd |
2001-11-20 |
Hepatopulmonary Syndrome; Diabetes Mellitus; Heart Defects, Congenital; Anemia, Sickle Cell; Persistent Fetal Circulation Syndrome; Ulcer; Glaucoma; Sleep Apnea Syndromes; Pulmonary Arterial Hypertension; Coronary Vasospasm; Lung Diseases, Interstitial; Hypertension, Pulmonary; Pulmonary Fibrosis; Hypertension; Fibrosis; Chronic thromboembolic pulmonary hypertension; Liver Cirrhosis; Sarcoidosis; Scleroderma, Systemic; Idiopathic Pulmonary Fibrosis; Diabetes Mellitus, Type 2; Heart Septal Defects, Atrial |
Details
|
Macitentan |
ACT-064992; Actelion-1; JNJ-67896062 |
Approved |
Actelion Pharmaceuticals Ltd |
Zependo, Opsumit, 傲朴舒 |
United States |
Pulmonary Arterial Hypertension |
Actelion Pharmaceuticals Us Inc |
2013-10-18 |
Hypertension, Pulmonary; Pulmonary Embolism; Heart Failure, Diastolic; Heart Failure; Scleroderma, Systemic; Chronic thromboembolic pulmonary hypertension; Idiopathic Pulmonary Fibrosis; Glioblastoma; Thromboembolism; Pulmonary Arterial Hypertension; Eisenmenger Complex; Scleroderma-associated interstitial lung diseases; Ulcer; Heart Defects, Congenital; Anemia, Sickle Cell; Chronic Disease |
Details
|
Aprocitentan |
JNJ-2820; ACT-132577; AC-080 |
Approved |
Actelion Pharmaceuticals Ltd, Idorsia Pharmaceuticals Ltd |
TRYVIO, JERAYGO |
United States |
Hypertension |
Idorsia Pharmaceuticals Ltd |
2024-03-19 |
Hypertension; Essential Hypertension; Hepatic Insufficiency; Renal Insufficiency, Chronic |
Details
|